Theracryf Statistics

Total Valuation

Theracryf has a market cap or net worth of GBP 5.43 million. The enterprise value is 1.32 million.

Market Cap	5.43M
Enterprise Value	1.32M

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Theracryf has 2.13 billion shares outstanding. The number of shares has increased by 95.83% in one year.

Current Share Class	2.13B
Shares Outstanding	2.13B
Shares Change (YoY)	+95.83%
Shares Change (QoQ)	+53.91%
Owned by Insiders (%)	27.89%
Owned by Institutions (%)	56.00%
Float	1.27B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.91
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.68
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11

Current Ratio	3.11
Quick Ratio	3.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.71% and return on invested capital (ROIC) is -31.95%.

Return on Equity (ROE)	-46.71%
Return on Assets (ROA)	-24.83%
Return on Invested Capital (ROIC)	-31.95%
Return on Capital Employed (ROCE)	-35.59%
Revenue Per Employee	n/a
Profits Per Employee	-215,667
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-144,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.85% in the last 52 weeks. The beta is 1.27, so Theracryf's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-73.85%
50-Day Moving Average	0.24
200-Day Moving Average	0.52
Relative Strength Index (RSI)	51.43
Average Volume (20 Days)	3,598,385

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-2.12M
Operating Income	-2.12M
Pretax Income	-2.09M
Net Income	-1.94M
EBITDA	-2.06M
EBIT	-2.12M
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 4.11 million in cash and n/a in debt, giving a net cash position of 4.11 million or 0.00 per share.

Cash & Cash Equivalents	4.11M
Total Debt	n/a
Net Cash	4.11M
Net Cash Per Share	0.00
Equity (Book Value)	5.97M
Book Value Per Share	0.00
Working Capital	3.51M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.37M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Theracryf does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.83%
Shareholder Yield	n/a
Earnings Yield	-35.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a